Moss, Norway

Tom Nilsen

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Gentian as. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tom Nilsen. Retrieved from https://idiyas.com/inventor/tom-nilsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Tom Nilsen

Introduction

Tom Nilsen is a notable inventor based in Moss, Norway. He has made significant contributions to the field of medical diagnostics, particularly through his innovative patents. With a total of three patents to his name, Nilsen has focused on enhancing the accuracy and efficiency of clinical assays.

Latest Patents

One of Nilsen's latest patents is a highly sensitive particle-enhanced assay for the quantification of NT-proBNP. This assay allows for the determination of NT-proBNP in biological samples using at least one antibody that recognizes an epitope of NT-proBNP in both glycosylated and non-glycosylated forms. The preferred antibody is an isolated polyclonal antibody or a mixture of monoclonal antibodies coated onto a particle, forming a layer or multiple layers of antibodies. This assay can be applied to a wide range of automated clinical analyzers, showcasing its versatility.

Another significant patent is a turbidimetric immunoassay for assessing human Cystatin C. This invention addresses the demand for improved turbidimetric immunoassays in biological samples, particularly in human clinical samples. The method and reagent set provided by this patent enable the measurement of human Cystatin C with a surprisingly stronger and faster turbidimetric signal. The use of new reagents and compositions enhances the assay's speed and quality, achieving improved robustness to lipid interference and better linearity.

Career Highlights

Tom Nilsen is currently associated with Gentian AS, where he continues to innovate in the field of medical diagnostics. His work has significantly impacted the development of clinical assays, making them more efficient and reliable.

Collaborations

Nilsen collaborates with talented individuals such as Ingvild Gudim and Torsten Knüttel, contributing to the advancement of their shared goals in medical technology.

Conclusion

Tom Nilsen's contributions to the field of medical diagnostics through his innovative patents demonstrate his commitment to improving clinical assays. His work continues to influence the industry positively, paving the way for more accurate and efficient medical testing methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…